Skip to main content
GILD logo
GILD
(NASDAQ)
Gilead Sciences, Inc.
$139.71-- (--)
Loading... - Market loading

Gilead Sciences (GILD) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Gilead Sciences Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Gilead Sciences, Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue29.4428.7527.1227.2827.3124.6922.4522.1326.11
Cost of Revenue3.926.256.505.666.604.574.684.854.37
Gross Profit25.5222.5021.1021.6220.7020.1217.7717.2721.74
Operating Expenses
Research & Development5.695.916.924.984.605.044.063.923.73
Selling, General & Administrative5.716.096.095.675.255.114.384.063.88
Operating Expenses13.7120.8411.8210.659.8516.058.447.987.61
Operating Income11.821.669.2810.9710.864.074.298.2014.12
Other Income/Expense
Interest Income0.000.280.380.110.000.000.000.000.00
Interest Expense1.020.98-0.940.941.000.981.001.081.12
Other Income/Expense-2.02-0.970.00-4.33-1.58-2.400.87-0.40-0.60
Income
Income Before Tax9.800.696.865.818.281.675.167.8013.53
Income Tax Expense1.290.211.251.252.081.58-0.202.348.89
Net Income8.510.485.674.596.230.125.395.464.63
Net Income - Continuous Operations8.510.485.674.576.200.125.395.464.63
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.000.00
EBITDA10.824.4310.308.8511.334.137.5610.3115.93
EBIT10.821.677.616.759.280.000.000.000.00
Depreciation & Amortization0.002.772.692.102.051.481.401.431.29
Earnings Per Share
Basic EPS7.00-5.004.005.00-4.004.004.00
Diluted EPS7.00-5.004.005.00-4.004.004.00
Basic Shares Outstanding1.241.251.251.261.261.261.271.301.31
Diluted Shares Outstanding1.261.261.261.261.261.261.281.311.32

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.